- Previous Close
4,335.00 - Open
4,310.00 - Bid 4,340.00 x --
- Ask 4,360.00 x --
- Day's Range
4,225.00 - 4,390.00 - 52 Week Range
3,970.00 - 9,400.00 - Volume
277,896 - Avg. Volume
352,633 - Market Cap (intraday)
258.369B - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 29, 2015
- 1y Target Est
--
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inositol; collagen peptide and collagen tripeptide for skin and health; chitoslim and chitosan oligosaccharides, as well as fucoxanthin, curezyme, food enzyme, and bamboo salt. It also offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, and feed sectors. In addition, the company offers K-nutra, a healthcare brand; and KeyClean, a disinfectant brand. Further, it provides protein purification resins. Amicogen, Inc. was founded in 2000 and is headquartered in Jinju-si, South Korea.
www.amicogen.com225
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 092040.KQ
View MorePerformance Overview: 092040.KQ
Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 092040.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 092040.KQ
View MoreValuation Measures
Market Cap
219.81B
Enterprise Value
369.45B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.63
Price/Book (mrq)
1.31
Enterprise Value/Revenue
2.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-23.21%
Return on Assets (ttm)
-0.64%
Return on Equity (ttm)
-18.16%
Revenue (ttm)
158.98B
Net Income Avi to Common (ttm)
-36.91B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
25.69B
Total Debt/Equity (mrq)
84.56%
Levered Free Cash Flow (ttm)
-109.87B